Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Abivax S.A. market cap for fiscal 2025 was $10.6B, a 2185.01% increase from fiscal 2024.
Abivax S.A. market cap for fiscal 2024 was $463.71M, a 31.13% decline from fiscal 2023.
Abivax S.A. market cap for fiscal 2023 was $673.34M.